Continuous Infusion of Ketamine and Lidocaine Either with or without Maropitant as an Adjuvant Agent for Analgesia in Female Dogs Undergoing Mastectomy

<div>Survival rate in female dogs submitted to unilateral radical mastectomy, continuous infusion of lidocaine and ketamine (GLK), and continuous infusion of lidocaine, ketamine, and maropitant (GLKM) during the six hours of postoperative evaluation. For the survival test, the first rescue received by each animal was considered.</div>

Veterinary Medicine International

fig2

Figure 2

Figure 2: Continuous Infusion of Ketamine and Lidocaine Either with or without Maropitant as an Adjuvant Agent for Analgesia in Female Dogs Undergoing Mastectomy 

Figure 2 | Continuous Infusion of Ketamine and Lidocaine Either with or without Maropitant as an Adjuvant Agent for Analgesia in Female Dogs Undergoing Mastectomy 